Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 10 Reduced Inequalities
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Impact of acute iTTP therapies on long term neurologic and cognitive outcomes in iTTP survivors study
Mazepa, M. (PI)
US THROMBOTIC MICROANGIOPATHY ALLIANCE
11/4/25 → 11/3/28
Project: Research project
-
Efgartigimod Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
Mazepa, M. (PI)
12/17/24 → 3/31/34
Project: Research project
-
A phase 3 randomized, double-blind study of ianalumab (VAY736) versus placebo in addition toeltrombopag in patients with primary immune thrombocytopenia (ITP) who had an insufficient response orrelapsed after first line steroid treatment (VAYHIT2
Mazepa, M. (PI)
NOVARTIS PHARMACEUTICALS CORPORATION
10/31/24 → 3/31/34
Project: Research project
-
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
Coppo, P., Bubenheim, M., Benhamou, Y., Völker, L., Brinkkötter, P., Kühne, L., Knöbl, P., Mingot-Castellano, M. E., Pascual-Izquierdo, C., de la Rubia, J., del Rio Garma, J., Chaturvedi, S., Masias, C., Mazepa, M., Zheng, X. L., Sinkovits, G., Réti, M., Patriquin, C. J., Pavenski, K. & Boechat, T. & 17 others, , Apr 2025, In: EClinicalMedicine. 82, 103168.Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Scopus citations -
Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyria
The Porphyrias Consortium of the Rare Diseases Clinical Research Network, Feb 19 2025, In: Hepatology Communications. 9, 3, 10.1097/HC9.0000000000000657.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura
Boothby, A. B., Evans, M. D., Yang, S., Sukumar, S., Scott, J. G., Terrell, D. R., Cataland, S. & Mazepa, M., Feb 2025, In: Journal of Clinical Medicine. 14, 3, 694.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
Fatola, A., Evans, M. D., Brown, J., Davis, E., Johnson, A., Antun, A. G., Farland, A. M., Woods, R., Metjian, A., Park, Y. A., de Ridder, G., Gibson, B., Kasthuri, R. S., Liles, D. K., Eubanks, S., Akwaa, F., Clover, T., Kreuziger, L. B., Sadler, J. E. & Sridharan, M. & 12 others, , Jan 28 2025, In: Blood Advances. 9, 2, p. 417-424 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Updated ISTH thrombotic thrombocytopenic purpura guidelines 2025—a bridge to the future for congenital thrombotic thrombocytopenic purpura
Story, C. M., Mazepa, M. A. & Chaturvedi, S., Nov 2025, In: Journal of Thrombosis and Haemostasis. 23, 11, p. 3437-3440 4 p.Research output: Contribution to journal › Comment/debate › peer-review